Immunotherapy Many innocent people suffer by sneezing in the spring or by living in constant fear of eating a food that could send them to the hospital. “Over 50 million of people suffer from allergies a year in the United States […] approximately 3 million [of the allergy sufferers have] found relief with allergen immunotherapy” (Communications). Ragweed allergy symptoms according to Nayak and others are, “sneezing; rhinorrhea/runny nose; itchy nose, throat, and palate; itchy, watery eyes; and nasal congestion/stuffiness.” According to Cox and more, allergy immunotherapy is, “for patients with allergic diseases, including rhinitis, allergic asthma, Hymenoptera sensitivity, and atopic dermatitis.” Allergy Immunotherapy is a treatment that
…show more content…
The patient has to wait at the office for twenty minutes after their shot to make sure that they do not have a life threatening, anaphylaxis reaction that can occur at any stage of shots. Swelling, slight pain, and redness can occur after shots and may linger for days. After a few months of building up the patient’s visits are decreased to every few weeks. The decreased visits are known as a maintenance dose. The whole treatment takes around four years. This method is good for treating multiple allergies since all of the serums can be combined into one or two shots. As a result of the possibility of an anaphylaxis reaction allergy shot immunotherapy is potentially deadly even though there is only very minute chance. The chance of a deadly reaction is only one for every two and one-half million shots, or three to four deaths every year (Slater …show more content…
OIT is sometimes confused with sublingual-swallow (SLIT) that is a dissolvable tablet placed under the tongue for two to three minutes (Canonica/ Durham). OIT is currently only available for allergic rhinitis which means grasses, ragweed, and other wed allergies. The FDA has approved only three pills which are Grastek, Oralair, and Ragwitek. Grastek is used to treat patients suffering from only timothy grass allergies (Howard 1). Whereas Ragwitek is only used in patients who are adversely affected by ragweed pollen (Howard 1). Finally, Oralair can be used to treat more allergens which are; timothy, orchard, perennial rye, Kentucky blue, and sweet vernal grasses (Howard 1). According to Office of Pharmacy Service Prior Authorization Criteria a person eligible to take Grastek if they are between the ages of sixty-five years-old (1). Oralair can only be used between the ages of 10 and 65 (Cox). The Oldest starting age, 18 to 65, is applied to Ragwitek (Cox). Grastek is offered for a larger and more effective age rage, but it can only be used to treat one allergen which makes it useless to the many allergy sufferers who poses multiple allergies (Howard 1). Oralair is used is a treatment the most allergens is, but it is unfortunately only available for the use of a smaller age rage (Howard 1). OIT has a reduced
The patient has to wait at the office for twenty minutes after their shot to make sure that they do not have a life threatening, anaphylaxis reaction that can occur at any stage of shots. Swelling, slight pain, and redness can occur after shots and may linger for days. After a few months of building up the patient’s visits are decreased to every few weeks. The decreased visits are known as a maintenance dose. The whole treatment takes around four years. This method is good for treating multiple allergies since all of the serums can be combined into one or two shots. As a result of the possibility of an anaphylaxis reaction allergy shot immunotherapy is potentially deadly even though there is only very minute chance. The chance of a deadly reaction is only one for every two and one-half million shots, or three to four deaths every year (Slater …show more content…
OIT is sometimes confused with sublingual-swallow (SLIT) that is a dissolvable tablet placed under the tongue for two to three minutes (Canonica/ Durham). OIT is currently only available for allergic rhinitis which means grasses, ragweed, and other wed allergies. The FDA has approved only three pills which are Grastek, Oralair, and Ragwitek. Grastek is used to treat patients suffering from only timothy grass allergies (Howard 1). Whereas Ragwitek is only used in patients who are adversely affected by ragweed pollen (Howard 1). Finally, Oralair can be used to treat more allergens which are; timothy, orchard, perennial rye, Kentucky blue, and sweet vernal grasses (Howard 1). According to Office of Pharmacy Service Prior Authorization Criteria a person eligible to take Grastek if they are between the ages of sixty-five years-old (1). Oralair can only be used between the ages of 10 and 65 (Cox). The Oldest starting age, 18 to 65, is applied to Ragwitek (Cox). Grastek is offered for a larger and more effective age rage, but it can only be used to treat one allergen which makes it useless to the many allergy sufferers who poses multiple allergies (Howard 1). Oralair is used is a treatment the most allergens is, but it is unfortunately only available for the use of a smaller age rage (Howard 1). OIT has a reduced